STRATA Skin Sciences, Inc. (SSKN)
NASDAQ: SSKN · Real-Time Price · USD
1.377
+0.077 (5.92%)
Nov 25, 2025, 4:00 PM EST - Market closed
STRATA Skin Sciences Employees
STRATA Skin Sciences had 106 employees as of December 31, 2024. The number of employees increased by 7 or 7.07% compared to the previous year.
Employees
106
Change (1Y)
7
Growth (1Y)
7.07%
Revenue / Employee
$292,264
Profits / Employee
-$102,585
Market Cap
8.11M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 106 | 7 | 7.07% |
| Dec 31, 2023 | 99 | -15 | -13.16% |
| Dec 31, 2022 | 114 | -1 | -0.87% |
| Dec 31, 2021 | 115 | 6 | 5.50% |
| Dec 31, 2020 | 109 | -6 | -5.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SSKN News
- 12 days ago - STRATA Skin Sciences, Inc. (SSKN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion - GlobeNewsWire
- 20 days ago - STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update - GlobeNewsWire
- 6 weeks ago - Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides - GlobeNewsWire
- 7 weeks ago - Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences' XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis - GlobeNewsWire
- 2 months ago - STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis - GlobeNewsWire
- 2 months ago - New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences' Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing Continued Validation of Personalized Medicine Approach - GlobeNewsWire
- 2 months ago - STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering - GlobeNewsWire